2022 - Research.com Best Female Scientist Award
Her primary areas of study are Internal medicine, Breast cancer, Odds ratio, Genome-wide association study and Case-control study. Her work carried out in the field of Internal medicine brings together such families of science as Endocrinology and Oncology. Her Breast cancer research is classified as research in Cancer.
Her Odds ratio research includes themes of Obstetrics, Physiology, Confidence interval and Risk factor. Xiao-Ou Shu has researched Genome-wide association study in several fields, including Genetic association, Bioinformatics and Genetic predisposition. Her Case-control study research incorporates themes from Endometrial cancer, Immunology and Confounding.
Xiao-Ou Shu focuses on Internal medicine, Breast cancer, Cancer, Oncology and Odds ratio. Within one scientific family, Xiao-Ou Shu focuses on topics pertaining to Endocrinology under Internal medicine, and may sometimes address concerns connected to Physiology. Her research in Breast cancer intersects with topics in Single-nucleotide polymorphism, Genome-wide association study, Genotype and Gynecology.
Her study in Cancer is interdisciplinary in nature, drawing from both Gastroenterology, Cancer research and Surgery. Her Oncology research integrates issues from Estrogen receptor, Pancreatic cancer and Pathology. Her Odds ratio study incorporates themes from Pregnancy, Endometrial cancer and Risk factor.
Xiao-Ou Shu mainly investigates Internal medicine, Breast cancer, Oncology, Cancer and Confidence interval. Prospective cohort study, Cohort study, Odds ratio, Lung cancer and Cohort are the primary areas of interest in her Internal medicine study. Her Breast cancer study integrates concerns from other disciplines, such as Cancer research, Genome-wide association study and Gene expression.
Her biological study deals with issues like Genetic association, which deal with fields such as Allele. Her research on Cancer focuses in particular on Colorectal cancer. Her Confidence interval research is multidisciplinary, relying on both Gastroenterology and Logistic regression.
Her main research concerns Internal medicine, Genome-wide association study, Oncology, Breast cancer and Hazard ratio. Her study in Cancer, Odds ratio, Confidence interval, Prospective cohort study and Lung cancer is carried out as part of her studies in Internal medicine. Her Odds ratio research is multidisciplinary, incorporating perspectives in Single-nucleotide polymorphism and Epidemiology.
Her Genome-wide association study study results in a more complete grasp of Genetics. Her Breast cancer study combines topics in areas such as CHEK2, Cancer research and Family history. Her Hazard ratio study combines topics from a wide range of disciplines, such as Cohort study, Young adult, Relative survival, Proportional hazards model and Confounding.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Kyriaki Michailidou;Per Hall;Anna Gonzalez-Neira;Maya Ghoussaini.
Nature Genetics (2013)
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
Ganna Chornokur;Hui-Yi Lin;Jonathan P. Tyrer;Kate Lawrenson.
PLOS ONE (2015)
Association between Body-Mass Index and Risk of Death in More Than 1 Million Asians
Wei Zheng;Dale F. McLerran;Betsy Rolland;Xianglan Zhang.
The New England Journal of Medicine (2011)
Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease
John E. Wagner;Joseph Rosenthal;Joseph Rosenthal;Robert Sweetman;Robert Sweetman;Xiao Ou Shu;Xiao Ou Shu.
Association analysis identifies 65 new breast cancer risk loci
Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley.
Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility.
Anubha Mahajan;Min Jin Go;Weihua Zhang;Jennifer E. Below.
Nature Genetics (2014)
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer
Laufey Amundadottir;Peter Kraft;Rachael Z. Stolzenberg-Solomon;Charles S. Fuchs.
Nature Genetics (2009)
Soyfood Intake during Adolescence and Subsequent Risk of Breast Cancer among Chinese Women
Xiao Ou Shu;Fan Jin;Qi Dai;Wanqing Wen.
Cancer Epidemiology, Biomarkers & Prevention (2001)
Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1
Wei Zheng;Jirong Long;Yu Tang Gao;Chun Li.
Nature Genetics (2009)
Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians
Yoon Shin Cho;Chien Hsiun Chen;Chien Hsiun Chen;Cheng Hu;Jirong Long.
Nature Genetics (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: